The global structural heart device market is expected to reach $9.7 billion by 2022

According to a new market report published by Lucintel, the future of the global structural heart device market looks promising with opportunities in public and private hospitals. The global structural heart device market is expected to reach an estimated $9.7 billion by 2022 and it is forecast to grow at a CAGR of 14.3% from 2017 to 2022. The major drivers for market growth are growing demand for minimally invasive surgery, growing healthcare expenditure, and a growing geriatric population.

In this market, annuloplasty, valvuloplasty, transcatheter mitral valve repair (TMVR), surgical heart valve, and transcatheter aortic valve replacement (TAVR) are the main segments by procedure type. On the basis of comprehensive research, Lucintel forecasts that the TAVR, TMVR, and tissue heart valve segments are expected to show above average growth during the forecast period.
http://www.lucintel.com/structural-heart-device-market-2017.aspx